Search research articles
Contact Us
Filters
Showing results (211-220 of 231) with videos related to
Page
of 24
Sort By:
The Pharmacogenomics Journal
|
October 5, 2016
A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials
A Sebio, S Stintzing, V Heinemann, et al.
Blood Cancer Journal
|
October 3, 2015
Rate of CRL4(CRBN) substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4
C C Bjorklund, L Lu, J Kang, et al.
The Pharmacogenomics Journal
|
October 28, 2015
Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer
Y Sunakawa, S Cao, M D Berger, et al.
American Journal of Human Genetics
|
June 28, 2000
An optimized set of human telomere clones for studying telomere integrity and architecture
S J Knight, C M Lese, K S Precht, et al.
British Journal of Cancer
|
May 24, 2012
Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis
Y S Lee, I Choi, Y Ning, et al.
Molecular and Cellular Biology
|
January 16, 1999
Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes
M J Bertram, N G Bérubé, X Hang-Swanson, et al.
The Pharmacogenomics Journal
|
February 12, 2014
Prospective study of EGFR intron 1 (CA)n repeats variants as predictors of benefit from cetuximab and irinotecan in chemo-refractory metastatic colorectal cancer (mCRC) patients
F Loupakis, C Antoniotti, C Cremolini, et al.
The Pharmacogenomics Journal
|
June 1, 2016
Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer
Y Sunakawa, S Cao, N B Volz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2015
Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials
Y Sunakawa, S Stintzing, S Cao, et al.
The Pharmacogenomics Journal
|
April 12, 2017
Prognostic impact of FOXF1 polymorphisms in gastric cancer patients
S Matsusaka, A H Wu, S Cao, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 231) with videos related to
Sort By:
Page
of 24
The Pharmacogenomics Journal
|
October 5, 2016
A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials
A Sebio, S Stintzing, V Heinemann, et al.
Blood Cancer Journal
|
October 3, 2015
Rate of CRL4(CRBN) substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4
C C Bjorklund, L Lu, J Kang, et al.
The Pharmacogenomics Journal
|
October 28, 2015
Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer
Y Sunakawa, S Cao, M D Berger, et al.
American Journal of Human Genetics
|
June 28, 2000
An optimized set of human telomere clones for studying telomere integrity and architecture
S J Knight, C M Lese, K S Precht, et al.
British Journal of Cancer
|
May 24, 2012
Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis
Y S Lee, I Choi, Y Ning, et al.
Molecular and Cellular Biology
|
January 16, 1999
Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes
M J Bertram, N G Bérubé, X Hang-Swanson, et al.
The Pharmacogenomics Journal
|
February 12, 2014
Prospective study of EGFR intron 1 (CA)n repeats variants as predictors of benefit from cetuximab and irinotecan in chemo-refractory metastatic colorectal cancer (mCRC) patients
F Loupakis, C Antoniotti, C Cremolini, et al.
The Pharmacogenomics Journal
|
June 1, 2016
Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer
Y Sunakawa, S Cao, N B Volz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2015
Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials
Y Sunakawa, S Stintzing, S Cao, et al.
The Pharmacogenomics Journal
|
April 12, 2017
Prognostic impact of FOXF1 polymorphisms in gastric cancer patients
S Matsusaka, A H Wu, S Cao, et al.
Page
of 24